Analysis of the Use of Acid Suppressing Medications in Hospitalized Children in a Pediatric General Ward by Puja, Dr. et al.
Puja et el                                                                                                                     Journal of Drug Delivery & Therapeutics. 2019; 9(5-s):50-52 
ISSN: 2250-1177                                                                                  [50]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.10.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                            Research Article  
Analysis of the Use of Acid Suppressing Medications in Hospitalized Children 
in a Pediatric General Ward 
Dr. Puja*, Dr. D.C. Dhasmana, Dr. Saurabh Kohli, Dr. Vipin Chander 
Department of Pharmacology, Himalayan Institute of Medical Sciences, Swami Ram Himalayan University, Doiwala, Dehradun, India 
 
ABSTRACT  
Background: Acid suppressants have been commonly prescribed in children and their efficacy and safety are under the lens. This 
observational study was envisaged to study the prevalence and pattern of use of acid suppressants in hospitalized children in pediatric general 
ward.  
Methods: 120 patients were included in the study. WHO indicators for rationality was used. Descriptive statistics was used to present the data 
i.e. percentage; proportions, frequency, mean and standard deviation using Microsoft excel worksheet. 
Results: 83 out of 120 patients received an acid suppressant. The most commonly prescribed acid suppressants was ranitidine. Proton pump 
inhibitors were also routinely prescribed.  
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INTRODUCTION:  
Acid-suppressing medications are used extensively in term 
and preterm newborns despite limited efficacy data and 
increasing evidence for potential harm. Use of acid 
suppressants is very common even  in hospitalized children 
and not just limited to NICUs. They are routinely prescribed 
even with limited safety and efficacy data. Non-indicated use 
of H2 blockers and proton pump inhibitors in hospitalized 
children is very rampant. Although benefits of acid 
suppression in infancy seem increasingly unlikely, adverse 
effects from PPI/H2 blockers treatment are now well 
documented (1,2) . Reduced gastric acidity, alteration of the 
gut microbiome and interference with neutrophil function 
result in increased risk of gastrointestinal infections in term 
infants and necrotizing enterocolitis in preterm infants. 
Treatment increases rates of community-acquired 
pneumonia even in healthy infants in the outpatient setting  
and is associated with ventilator-associated pneumonia in 
the PICU and late onset sepsis in the NICU. Gastric pH 
changes impede calcium absorption with potentially harmful 
effects on bone development and increased risk of 
fractures. Adverse effects are of particular concern for 
neonates and premature infants, whose relative liver 
immaturity may result in delayed drug metabolism(1-3). 
Although there are concerns over use of acid suppressing 
medications in term and preterm newborns with limited 
evidence of efficacy and documentation of adverse effects 
the use of acid suppressants rather non indicated use of acid 
suppressants in children has not been much talked about. In 
this study we have analysed the use of acid suppressing 
medications in hospitalized children in a pediatric general 
ward at a tertiary care teaching hospital in north India. 
MATERIALS AND METHODS:  
This observational cross-sectional study was carried out in 
Himalayan Institute of Medical Sciences, Swami Ram Nagar, 
Dehradun, in the Department of Pharmacology and the 
Department of Pediatrics over a period of twelve months 
after obtaining ethical clearance from the Institutional Ethics 
Committee .  
Sample size: 
A total of 120 patients admitted in the pediatric general 
ward were included in the study. 
Inclusion criteria 
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Patients less than   18 years of age admitted in pediatric 
general ward with minimum 5 days of stay in the hospital.  
Exclusion criteria 
1.Oncological patients and those with chronic diseases  
3. Patients admitted in pediatric or neonatal  intensive care 
Study tools 
Patient case recording form 
Summary of product /drug monogram  
Study protocol 
Patient details (age, weight, anthropometric measurements), 
prescription drug  details(indication, dose, frequency) and 
other relevant information were recorded as per the case 
recording form after obtaining written informed consent 
from parent/legal  guardian and assent from school going 
children. 
Data Management and Statistical Analysis 
Descriptive statistics were used to present the data i.e. 
percentage; proportions, frequency, mean and standard 
deviation using Microsoft excel worksheet 
Result: Out of 120 patients 83 received an acid suppressant. 
Out of 791 drugs prescribed to the total 120 patients 94 acid 
suppressants were prescribed. Most commonly prescribed 
acid suppressant was ranitidine followed by combination of 
magnesium hydroxide, simethicone, sodium 
carboxymethylcellulose, aluminium hydroxide and close 
third was combination of simethicone and magaldrate. 
About 85percent of the acid suppressants were prescribed 
by trade name. Out of the 83 patients who were prescribed 
acid suppressants 11 were prescribed more than one acid 
suppressants. 53percent of the acid suppressants prescribed 
was from WHO Essential List of Medicine for Children 2019. 
39 percent of the acid suppressants were prescibed by 
parenteral route. About 10% of the total patients were 
prescribed off-label proton pump inhibitors (pantoprazole 
and lansoprazole). for which their product label mentions 
that safety and efficacy  has not been established in children. 
  
 
 
 
 
DISCUSSION  
In our study the acid lowering agents were 11.3% which is 
higher than 4.4% observed in other similar study from Nepal 
and 3.1% in other similar study from pediatric general 
wardin five different countries but similar to 9.4% in a 
similar study from south india, the reason for this 
observation may be due to the etiology of the disease for 
which the patient were admitted s(4-7). In our study 85% of 
the acid suppressants were prescribed by trade name which 
is higher from other similar studies. In this study 53% of the 
acid suppressants were from WHO essential list of medicine. 
In other similar studies these  analysis for acid suppressants 
was not done for these class of drugs specifically. 
In our study the most commonly prescribed acid 
suppressant used was ranitidine and the recent issue about 
its safety is a matter of great concern as it is commonly 
prescribed to children. About 10% of the total patients were 
prescribed off-label proton pump inhibitors (pantoprazole 
and lansoprazole) as  their product label mentions that 
safety and efficacy  has not been established in children. 
There are increasing evidence that they may affect bone 
growth, immunity and affect response to allergens.  
CONCLUSION:  
Findings of this study emphasizes  the need of rational 
prescribing and also underlines that the need of the hour is 
to provide safe and effective medicine for our children and 
not treat them as mere miniature adults.  
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